← Back to markets
Silence Therapeutics
SLN · Health Care · Biotechnology
$13.53-1.03%
RS +63.5
Returns
| 7D | -0.6% |
| 1M | +17.1% |
| 3M | +99.0% |
| 6M | +152.9% |
| YTD | +122.5% |
| 1Y | +167.4% |
About Silence Therapeutics
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.